Engineering Red Blood Cells to Carry Therapeutic Cargo
Whitehead Institute scientists have genetically and enzymatically modified red blood cells to carry a range of valuable payloads—from drugs, to ...
Tag: Antitoxins
Squid Enzymes Could Help Neutralize Chemical Weapons
Nerve agent sarin bound to bioscavenger enzyme. Courtesy of UT. Researchers at the University of Tennessee at Knoxville (UT) are ...
USAMRICD Hosts Chemical Defense Bioscience Review
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) hosted its 19th Biennial Medical Defense Bioscience Review, “Advances in ...
FDA Medical Countermeasures Initiative Symposium
FDA’s Medical Countermeasures initiative (MCMi) will host their annual Regulatory Science Symposium this week at FDA Headquarters in Silver Springs, Md. ...
RFI – Advance Development of Broad Spectrum Countermeasures
The Department of Defense seeks to identify candidate medical countermeasures and supporting technologies for the Emerging Infectious Diseases Therapeutics (EID ...
RFI – Optimizing Therapeutic Compounds against Priority Pathogens
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical product developers regarding their efforts toward ...
NIAID Concepts for Multiplex Diagnostics, Small Molecule Therapeutics
The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) has approved three new ...
Hawaii Biotech Awarded Grant for Anthrax Anti-Toxin
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Hawaii Biotech, Inc. a grant to continue the development ...
PharmAthene and Theraclone Sciences Announce Merger Agreement
Biodefense therapeutics developer PharmAthene, Inc. and Theraclone Sciences, Inc., a privately-held monoclonal antibody (mAb) discovery and development company, last week ...
Animal Study Results for Intramuscular Anthrax Anti-Toxin
Elusys Therapeutics, Inc. this week released data from three recently completed studies of ETI-204, an investigational anti-toxin agent in late ...
BARDA Announces BAA for CBRN Medical Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) this week announced a new solicitation for proposals that advance medical countermeasures ...
Proposals Sought for Medical Countermeasure Storage
The U.S. federal government is seeking contractor proposals for the storage and management of a critical medical asset stockpile. The ...
FDA Approves First Antitoxin to Neutralize All 7 Botulism Serotypes
The U.S. Food and Drug Administration last week announced that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, ...
NIAID Seeks Proposals for Broad Spectrum Biodefense Countermeasures
National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) in support of the ...
BARDA Seeks Antitoxins for Treatment of Inhalational Anthrax
The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Proposals (RFP) for anthrax antitoxin products to ...
BARDA CBRN Medical Countermeasures Pre-Proposal Conference
The Biomedical Advanced Research and Development Authority (BARDA) has formally released BARDA-CBRN-BAA-12-100-SOL-00011 for “Advanced Research and Development of Chemical, Biological, Radiological, ...
BARDA to Open New BAA for CBRN Medical Countermeasures
Biomedical Advanced Research and Development Authority (BARDA) will release a new Broad Agency Announcment (BAA) on 4 March, 2012 for ...
